People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

Seven-year follow-up data show that transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement have ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...

The Central Chest Institute of Thailand (CCIT) in Nonthaburi has adopted the Tavi procedure to treat aortic valve stenosis, a ...

More than 10 million older adults in the U.S. have mild or greater valvular heart disease and the prevalence is expected to grow over the next several decades, according to data from the PREVUE-VALVE ...

PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and ...

A troubling rise in severe diverticulitis cases among Americans under 50 highlights a significant public health concern.

Anteris Technologies has won FDA approval to conduct a key clinical trial for its heart valve device in the US.

Edwards Lifesciences has raised its fiscal year (FY25) guidance to between $2.56 to $2.62 per share after achieving better ...

Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.